DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 124 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $3,830,327 | -26.9% | 233,699 | -17.5% | 0.02% | -25.0% |
Q3 2022 | $5,242,000 | +11.9% | 283,348 | -20.4% | 0.03% | +16.7% |
Q2 2022 | $4,683,000 | -18.1% | 356,138 | -42.3% | 0.02% | -25.0% |
Q1 2022 | $5,718,000 | +31.9% | 616,873 | +39.0% | 0.03% | +33.3% |
Q4 2021 | $4,336,000 | +115.9% | 443,762 | +1275.5% | 0.02% | -38.5% |
Q4 2019 | $2,008,000 | +106.4% | 32,263 | +12.6% | 0.04% | +129.4% |
Q3 2019 | $973,000 | – | 28,654 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |